Gene: S100A10

6281
42C|ANX2L|ANX2LG|CAL1L|CLP11|Ca[1]|GP11|P11|p10
S100 calcium binding protein A10
protein-coding
1q21.3
Ensembl:ENSG00000197747 MIM:114085 Vega:OTTHUMG00000013068 UniprotKB:P60903
NC_000001.11
PubMed
CD|ND|AD
5   
2.720e-1 (AD)  4.842e-1 (ND)   (Frontal_Cortex)
7.009e-1 (AD)  5.984e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
ANXA20.882
TAGLN20.876
S100A110.858
PLP20.852
CLIC10.847
MYL12A0.834
TIMP10.829
GBP20.822
CD440.822
WWTR10.818

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
NEUROD6-0.55
ABCC12-0.537
KIT-0.531
MARCH4-0.522
EXTL1-0.512
ADRA1D-0.509
FBLN7-0.507
PPEF1-0.503
CALHM1-0.495
SLC7A4-0.494

Drugs/Compounds

ID Drug Name Drug Type CAS Num Status Role
DB12695Phenethyl IsothiocyanateSmall Molecule2257-09-2InvestigationalTarget
ID Drug Name Action PubMed
C0264861,2,5,6-dibenzanthracene"1,2,5,6-dibenzanthracene results in decreased expression of S100A10 mRNA"26377693
C0493251,2-dithiol-3-thione"1,2-dithiol-3-thione results in increased expression of S100A10 mRNA"15302862
C0493251,2-dithiol-3-thione"1,2-dithiol-3-thione results in decreased expression of S100A10 mRNA"19162173
C0284741,4-bis(2-(3,5-dichloropyridyloxy))benzene"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of S100A10 mRNA"28903501
C1111182',3,3',4',5-pentachloro-4-hydroxybiphenyl"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of S100A10 mRNA"19114083
C0294972,3-bis(3'-hydroxybenzyl)butyrolactone"[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of S100A10 mRNA"19167446
C0164032,4-dinitrotoluene"2,4-dinitrotoluene affects the expression of S100A10 mRNA"21346803
C0235142,6-dinitrotoluene"2,6-dinitrotoluene affects the expression of S100A10 mRNA"21346803
C0230353,4,5,3',4'-pentachlorobiphenyl"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of S100A10 mRNA"19692669
C4727913-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of S100A10 mRNA16788091
C0179063-dinitrobenzene3-dinitrobenzene results in increased expression of S100A10 mRNA21983209
C0095054,4'-diaminodiphenylmethane"4,4'-diaminodiphenylmethane results in increased expression of S100A10 mRNA"18648102
C0095054,4'-diaminodiphenylmethane"4,4'-diaminodiphenylmethane results in increased expression of S100A10 mRNA"25380136
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
D000082AcetaminophenAcetaminophen results in decreased expression of S100A10 mRNA21420995
D000082AcetaminophenAcetaminophen affects the expression of S100A10 mRNA17562736
D000082Acetaminophen[Clofibrate co-treated with Acetaminophen] affects the expression of S100A10 mRNA17585979
D000082AcetaminophenPPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of S100A10 mRNA]17585979
D016604Aflatoxin B1Aflatoxin B1 affects the expression of S100A10 protein20106945
D016604Aflatoxin B1Aflatoxin B1 results in decreased methylation of S100A10 gene27153756
D000452AldrinAldrin results in increased expression of S100A10 mRNA18579281
D0150812-Naphthylamine2-Naphthylamine results in increased expression of S100A10 mRNA18247414
D000638AmiodaroneAmiodarone results in increased expression of S100A10 mRNA24535564
D000643Ammonium ChlorideAmmonium Chloride affects the expression of S100A10 mRNA16483693
C006632arsenic trioxidearsenic trioxide results in increased expression of S100A10 mRNA15949261
C006632arsenic trioxideS100A10 protein results in decreased susceptibility to arsenic trioxide20707922
C015001arsenitearsenite affects the expression of S100A10 mRNA22959463
D001205Ascorbic AcidAscorbic Acid results in increased expression of S100A10 mRNA15372504
C487081belinostatbelinostat results in increased expression of S100A10 mRNA26272509
C487081belinostat"[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
D001554BenzeneBenzene results in decreased expression of S100A10 mRNA20036648
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of S100A10 mRNA18247414
D001564Benzo(a)pyreneAHR protein promotes the reaction [Benzo(a)pyrene results in decreased expression of S100A10 mRNA]15034205
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of S100A10 mRNA15034205|2719552
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of S100A10 mRNA22228805
D0151237,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of S100A10 mRNA"20018196
D004958EstradiolEstradiol results in decreased expression of S100A10 mRNA23019147
D004958EstradiolEstradiol results in increased expression of S100A10 mRNA19484750
D004958Estradiol[Progesterone co-treated with Estradiol] results in increased expression of S100A10 protein17446234
D004958Estradiol[bisphenol A co-treated with Estradiol] results in increased expression of S100A10 mRNA26496021
C095105bexarotenebexarotene results in decreased expression of S100A10 mRNA16648578
D001663BilirubinBilirubin results in decreased expression of S100A10 mRNA20196124
C006780bisphenol Abisphenol A results in increased expression of S100A10 mRNA28159858
C006780bisphenol A[bisphenol A co-treated with Estradiol] results in increased expression of S100A10 mRNA26496021
C006780bisphenol Abisphenol A results in increased expression of S100A10 mRNA25181051
D019256Cadmium ChlorideCadmium Chloride results in increased expression of S100A10 mRNA26472689
D019256Cadmium ChlorideCadmium Chloride affects the expression of S100A10 mRNA22110744
D019256Cadmium ChlorideCadmium Chloride results in increased expression of S100A10 mRNA25993096
D002220CarbamazepineCarbamazepine affects the expression of S100A10 mRNA25979313
D002251Carbon TetrachlorideCarbon Tetrachloride affects the expression of S100A10 mRNA17484886
D002251Carbon TetrachlorideCarbon Tetrachloride results in increased expression of S100A10 mRNA27339419
D002251Carbon TetrachlorideCarbon Tetrachloride results in increased expression of S100A10 mRNA16239168
C043211carvedilolcarvedilol results in decreased expression of S100A10 protein20403466
D020245p-Chloromercuribenzoic Acid"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
C100187chloropicrinchloropicrin results in decreased expression of S100A10 mRNA26352163
D015283CitalopramCitalopram affects the expression of S100A10 mRNA21682946
D002994Clofibrate[Clofibrate co-treated with Acetaminophen] affects the expression of S100A10 mRNA17585979
D002994ClofibratePPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of S100A10 mRNA]17585979
D002995Clofibric Acid[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of S100A10 mRNA17602206
D019327Copper SulfateCopper Sulfate results in increased expression of S100A10 mRNA19549813
D019327Copper SulfateCopper Sulfate results in increased expression of S100A10 mRNA18579281
D003375Coumestrol"[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of S100A10 mRNA"19167446
D016572CyclosporineCyclosporine affects the expression of S100A10 mRNA25562108
D016572CyclosporineCyclosporine results in increased expression of S100A10 mRNA21865292
D003561CytarabineCytarabine results in decreased expression of S100A10 mRNA21198554
C014347decitabinedecitabine affects the expression of S100A10 mRNA23300844
C014347decitabinedecitabine affects the methylation of S100A10 gene17579622
C014347decitabine[decitabine co-treated with vorinostat] affects the expression of S100A10 mRNA17330099
C014347decitabinedecitabine results in increased expression of S100A10 mRNA19151715
D003993Dibutyl PhthalateDibutyl Phthalate results in decreased expression of S100A10 mRNA17379624
D003993Dibutyl PhthalateDibutyl Phthalate results in increased expression of S100A10 mRNA21266533
D003999Dichloroacetic AcidDichloroacetic Acid results in increased expression of S100A10 mRNA28962523
D002945CisplatinCisplatin affects the expression of S100A10 mRNA23300844
D002945CisplatinCisplatin results in increased expression of S100A10 mRNA21151649
C036042dicyclohexyl phthalatedicyclohexyl phthalate affects the expression of S100A10 mRNA26924002
D004026DieldrinDieldrin results in increased expression of S100A10 mRNA23041725
D004041Dietary FatsDietary Fats results in decreased expression of S100A10 mRNA18042831
D004041Dietary FatsDietary Fats results in increased expression of S100A10 mRNA15238619|2260994
D004041Dietary FatsNEIL1 affects the reaction [Dietary Fats results in increased expression of S100A10 mRNA]21285402
D004051Diethylhexyl PhthalateDiethylhexyl Phthalate results in increased expression of S100A10 mRNA19850644
D004051Diethylhexyl PhthalatePPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of S100A10 mRNA]19850644
D004052Diethylnitrosamine[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of S100A10 mRNA17602206
D004052Diethylnitrosamine[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of S100A10 mRNA28943392
D004052DiethylnitrosamineDiethylnitrosamine results in increased expression of S100A10 mRNA19638242
D002117CalcitriolCalcitriol results in increased expression of S100A10 mRNA21592394
D002117Calcitriol[Testosterone co-treated with Calcitriol] results in increased expression of S100A10 mRNA21592394
D004128DimethylnitrosamineDimethylnitrosamine results in increased expression of S100A10 mRNA25380136
D004137DinitrochlorobenzeneDinitrochlorobenzene results in increased expression of S100A10 mRNA16314067
D004237DiuronDiuron results in decreased expression of S100A10 mRNA21551480
C118739entinostatentinostat results in increased expression of S100A10 mRNA26272509
C118739entinostat"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
D004791Enzyme Inhibitors[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of S100A10 protein23301498
D004997Ethinyl Estradiol[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of S100A10 mRNA17942748
D004997Ethinyl EstradiolEthinyl Estradiol results in increased expression of S100A10 mRNA17557909
D011345FenofibrateFenofibrate results in increased expression of S100A10 mRNA11798191
D005419FlavonoidsFlavonoids results in decreased expression of S100A10 mRNA18035473
D005472FluorouracilFluorouracil results in increased expression of S100A10 mRNA16557594
D005492Folic AcidFolic Acid affects the expression of S100A10 mRNA17320366
D005557FormaldehydeFormaldehyde inhibits the reaction [H3F3A protein binds to S100A10 promoter]28937961
D005557FormaldehydeFormaldehyde results in decreased expression of S100A10 mRNA20655997
D005557FormaldehydeFormaldehyde results in increased expression of S100A10 mRNA12679049
C056933fumonisin B1fumonisin B1 results in increased expression of S100A10 mRNA16221962
C039281furanfuran results in decreased methylation of S100A10 gene27387713
C039281furanfuran results in increased expression of S100A10 mRNA20124500|2619464
D005839GentamicinsGentamicins results in increased expression of S100A10 mRNA22061828
D017313FenretinideFenretinide results in decreased expression of S100A10 mRNA28973697
D015759Ionomycin[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of S100A10 mRNA25613284
C410337K 7174K 7174 results in increased expression of S100A10 mRNA24086573
C008261lead acetatelead acetate results in increased expression of S100A10 mRNA20542052
C045463leflunomideleflunomide results in decreased expression of S100A10 mRNA24136188
D058185Magnetite Nanoparticles[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of S100A10 mRNA21641980
C025340manganese chlorideS100A10 protein affects the susceptibility to manganese chloride24067723
C042720mercuric bromidemercuric bromide results in increased expression of S100A10 mRNA26272509
C042720mercuric bromide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
C004925methylmercuric chloridemethylmercuric chloride results in decreased expression of S100A10 mRNA23179753|2718838
C004925methylmercuric chloridemethylmercuric chloride results in increased expression of S100A10 mRNA23179753|2627250
C004925methylmercuric chloride"[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
D008777MethyltestosteroneMethyltestosterone results in decreased expression of S100A10 mRNA29191790
C045621miglitolmiglitol results in decreased expression of S100A10 mRNA20667563
D016685MitomycinS100A10 protein affects the susceptibility to Mitomycin16217747
C028577monobutyl phthalatemonobutyl phthalate affects the expression of S100A10 mRNA19162170
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in decreased expression of S100A10 mRNA"25620056
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in increased expression of S100A10 mRNA"25554681
D037742Nanotubes, Carbon"Nanotubes, Carbon results in increased expression of S100A10 mRNA"25554681
D0150581-Naphthylisothiocyanate1-Naphthylisothiocyanate results in increased expression of S100A10 mRNA25380136
C017096n-butoxyethanoln-butoxyethanol results in decreased expression of S100A10 mRNA19812364
C029938nickel sulfatenickel sulfate results in increased expression of S100A10 mRNA16314067
D009538NicotineNicotine results in decreased expression of S100A10 mRNA18247414
C014707nitrosobenzylmethylaminenitrosobenzylmethylamine results in increased expression of S100A10 mRNA17616710
C030110oxaliplatinoxaliplatin results in decreased expression of S100A10 mRNA25729387
D010100OxygenOxygen deficiency results in increased expression of S100A10 mRNA26516004
D010100OxygenOxygen results in increased expression of S100A10 mRNA22911455
D000073878Palm OilPalm Oil results in decreased expression of S100A10 mRNA18042831
C496932panobinostat"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
C496932panobinostatpanobinostat results in increased expression of S100A10 mRNA26272509
C058305phenethyl isothiocyanateS100A10 protein binds to phenethyl isothiocyanate21838287
D010634PhenobarbitalPhenobarbital affects the expression of S100A10 mRNA19159669
D010634PhenobarbitalNR1I3 protein affects the reaction [Phenobarbital results in increased expression of S100A10 mRNA]19482888
D010634PhenobarbitalPhenobarbital affects the expression of S100A10 mRNA23091169
D010634PhenobarbitalPhenobarbital results in increased expression of S100A10 mRNA19482888
D010662Phenylmercuric Acetate"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
D010662Phenylmercuric AcetatePhenylmercuric Acetate results in increased expression of S100A10 mRNA26272509
D010672PhenytoinPhenytoin results in increased expression of S100A10 mRNA14741686
C006253pirinixic acidpirinixic acid results in increased expression of S100A10 mRNA11798191|1530286
C006253pirinixic acidPPARA protein promotes the reaction [pirinixic acid results in increased expression of S100A10 mRNA]20059764
D011374ProgesteroneProgesterone results in decreased expression of S100A10 mRNA23018184
D011374ProgesteroneProgesterone results in increased expression of S100A10 mRNA23018184
D011374ProgesteroneProgesterone results in increased expression of S100A10 mRNA21795739
D011374Progesterone[Progesterone co-treated with Estradiol] results in increased expression of S100A10 protein17446234
D011374ProgesteroneProgesterone results in increased expression of S100A10 protein17446234
C045950propiconazolepropiconazole results in increased expression of S100A10 mRNA21278054
D011441PropylthiouracilPropylthiouracil results in increased expression of S100A10 mRNA24780913
D012715Sesame OilSesame Oil results in increased expression of S100A10 mRNA29191790
C017947sodium arsenitesodium arsenite results in decreased expression of S100A10 mRNA25879800
C017947sodium arsenitesodium arsenite results in increased expression of S100A10 mRNA12377979
C017947sodium arsenitesodium arsenite results in increased expression of S100A10 mRNA21297353
C016104sodium bichromatesodium bichromate results in increased expression of S100A10 mRNA25993096
D004113Succimer[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of S100A10 mRNA21641980
D013739Testosterone[Testosterone co-treated with Calcitriol] results in increased expression of S100A10 mRNA21592394
D013739TestosteroneTestosterone results in increased expression of S100A10 mRNA21592394
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of S100A10 mRNA21570461
D013749Tetrachlorodibenzodioxin[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of S100A10 mRNA17942748
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of S100A10 mRNA15034205|2892240
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of S100A10 mRNA19692669
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of S100A10 mRNA20959002
D013755Tetradecanoylphorbol Acetate[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of S100A10 mRNA25613284
D013853Thioacetamide[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of S100A10 mRNA28943392
D013853ThioacetamideThioacetamide results in increased expression of S100A10 mRNA23411599
C066340tolcaponetolcapone results in decreased expression of S100A10 mRNA24136188
D014212TretinoinTretinoin results in increased expression of S100A10 mRNA23724009
D014212TretinoinTretinoin results in decreased expression of S100A10 mRNA16788091
D014241TrichloroethyleneTrichloroethylene results in increased expression of S100A10 mRNA19448997
C012589trichostatin A"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
C012589trichostatin Atrichostatin A results in increased expression of S100A10 mRNA24935251|2627250
C012589trichostatin Atrichostatin A results in decreased expression of S100A10 mRNA15901671
C016805tris(1,3-dichloro-2-propyl)phosphate"tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of S100A10 mRNA"26179874
C057693troglitazonetroglitazone results in increased expression of S100A10 mRNA28973697
D014520UrethaneUrethane results in decreased expression of S100A10 mRNA28818685
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
D014635Valproic AcidValproic Acid results in increased expression of S100A10 mRNA23179753|2438349
D014635Valproic AcidValproic Acid affects the expression of S100A10 mRNA17963808
D014635Valproic AcidValproic Acid results in increased expression of S100A10 mRNA24535564|2489608
D014635Valproic AcidValproic Acid results in decreased expression of S100A10 mRNA23665938
D014635Valproic AcidValproic Acid results in decreased expression of S100A10 mRNA15901671
D014640VancomycinVancomycin results in decreased expression of S100A10 mRNA18930951
D001335Vehicle EmissionsVehicle Emissions results in decreased methylation of S100A10 gene25560391
C025643vinclozolinvinclozolin affects the expression of S100A10 mRNA19015723
C025643vinclozolinvinclozolin results in increased expression of S100A10 mRNA23034163
D014752Vinyl ChlorideVinyl Chloride results in increased expression of S100A10 mRNA18579281
C111237vorinostat[decitabine co-treated with vorinostat] affects the expression of S100A10 mRNA17330099
C111237vorinostat"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA"27188386
C111237vorinostatvorinostat results in increased expression of S100A10 mRNA26272509

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0005509calcium ion binding-IEA-  
GO:0005515protein binding-IPI14699089  23091277  23415230  24457100  26941067  
GO:0008289lipid bindingNOTIDA23861394  
GO:0042803protein homodimerization activity-IDA23091277  
GO:0044325ion channel binding-IPI12198146  
GO ID GO Term Qualifier Evidence PubMed
GO:0001765membrane raft assembly-IDA23861394  
GO:0006900vesicle budding from membrane-IDA23861394  
GO:0042493response to drug-IEA-  
GO:0043547positive regulation of GTPase activity-IMP23129259  
GO:0051099positive regulation of binding-IEA-  
GO:0051290protein heterotetramerization-IDA23091277  23861394  
GO:0051496positive regulation of stress fiber assembly-IMP23129259  
GO:0051894positive regulation of focal adhesion assembly-IMP23129259  
GO:0072659protein localization to plasma membrane-IDA12198146  
GO:1900026positive regulation of substrate adhesion-dependent cell spreading-IMP23129259  
GO ID GO Term Qualifier Evidence PubMed
GO:0005576extracellular region-HDA27068509  
GO:0005783endoplasmic reticulum-IEA-  
GO:0019897extrinsic component of plasma membrane-IEA-  
GO:0045121membrane raftcolocalizes_withIDA14699089  
GO:0070062extracellular exosome-HDA19056867  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence
R-HSA-109582HemostasisTAS
R-HSA-75205Dissolution of Fibrin ClotTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
26227246Susceptibility loci for heroin and cocaine addiction in the serotonergic and adrenergic pathways in populations of different ancestry. (2015)Levran OPharmacogenomics
24725970Cell-type specific expression of p11 controls cocaine reward. (2014 Nov 15)Arango-Lievano MBiol Psychiatry
28652369Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival. (2017 Jul 11)Gocheva VProc Natl Acad Sci U S A
26059306[Depression and addiction comorbidity: towards a common molecular target?]. (2015 May)Arango-Lievano MMed Sci (Paris)
28418321S100A10 identified in a genome-wide gene x cannabis dependence interaction analysis of risky sexual behaviours. (2017 Jun)Polimanti RJ Psychiatry Neurosci